June 10, 2026
Headlines

Aeovian Pharmaceuticals Secures $55 Million to Revolutionize Treatment for Refractory Tuberous Sclerosis Complex Epilepsy

Editor09 mins

Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company focused on restoring cellular metabolic quality control, has successfully closed an oversubscribed $55 million Series B financing. This substantial investment is earmarked to propel the development of its lead candidate, AV078, a first-in-class, CNS-penetrant selective mTORC1 inhibitor, and finance the completion of its crucial Phase 2 proof-of-concept study. The…

Read More

Eco.mio Secures Seven-Figure Seed Funding to Expand Sustainable Business Travel Solutions Across Europe

Editor04 mins

Berlin-based B2B startup Eco.mio has raised a substantial seed funding round described as “low seven-figures,” marking a pivotal moment in its mission to revolutionize sustainable business travel practices. The financing round was led by prominent investors including IBB Ventures, Identity.vc, the Hans(wo)men Group, N&V Capital, Partners in Clime, and several individual backers. Founded in 2021,…

Read More

Ubie Surpasses $125M in Funding to Drive Generative AI & Provider Tools for Smarter Healthcare

Editor04 mins

Ubie, founded in 2017, has announced it has now secured over $125 million in cumulative funding, as it accelerates its expansion into the U.S. with generative AI and provider-focused solutions. The milestone builds upon the company’s previous $26.2M Series C, bringing total backing to more than $59.8M since the previous raise in August 2022. Led…

Read More

ConfidentialMind Secures €1.5 Million to Pave the Way for On-Premises Generative AI

Editor03 mins

In a significant stride towards advancing enterprise and government applications of generative AI, Espoo-based startup ConfidentialMind has raised €1.5 million in a pre-seed funding round. This investment, spearheaded by Failup Ventures and complemented by participation from Angel CoFund and notable angel investors, marks a pivotal moment for the company founded just a year ago. Founded…

Read More

Zencity Raises $40 Million to Advance AI in Local Government Trust-Building Efforts

Editor05 mins

Zencity, a prominent community engagement platform serving the local government sector across four continents, has secured a significant $40 million investment in its Series C funding round led by StepStone Group. This latest infusion of capital, which includes participation from existing investor TLV Partners, brings the total raised by the company to $91 million and…

Read More

Hgen Secures $5M Funding to Advance High-Efficiency Electrolyzer Technology

Editor05 mins

In a significant boost to the clean hydrogen sector, Hgen, a pioneering startup focused on decarbonizing heavy industry, has announced the successful closure of a $5 million seed financing round. The investment, led by Seven Seven Six, with notable participation from Founders Fund and Fontinalis Partners, will expedite the commercial deployment of Hgen’s innovative alkaline…

Read More

Vital Lyfe Raises $24M Seed Round, Applying Aerospace Engineering to Redefine Global Water Access

Editor07 mins

Vital Lyfe, a technology company founded by former SpaceX engineering leadership, today announced it has secured $24 million in funding to accelerate the rollout of its revolutionary, portable water-making systems. The capital—comprising over $18 million in seed funding and committed debt financing—validates the company’s mission to decouple clean water access from centralized, outdated infrastructure. The…

Read More

Smartville Inc. Secures $10M Grant from DOE OCED to Propel Long-Duration Energy Storage Innovations

Editor04 mins

Smartville Inc., a pioneering force in EV battery circularity based in Carlsbad, California, proudly announces its partnership with the U.S. Department of Energy Office of Clean Energy Demonstrations (OCED) for a transformative $10 million grant under the Long-Duration Energy Storage (LDES) Demonstrations Program’s Second-Life Smart Systems (SMART) project. This substantial funding marks a pivotal step…

Read More

Formation Bio Secures $372 Million Series D Funding to Propel AI-Driven Drug Development

Editor07 mins

Formation Bio, a pioneering force at the intersection of technology and pharmaceuticals, has announced a landmark achievement with the closure of a $372 million Series D financing round. This funding round was led by prominent investors including a16z and Sanofi, with continued support from existing backers such as Sequoia, Thrive, Emerson Collective, and Lachy Groom,…

Read More